Bacterial expression and antibiotic activities of recombinant variants of human β-defensins on pathogenic bacteria and M. tuberculosis

Protein Expression and Purification

Volumn 89, Issue 1, 2013, Pages 33-43

  Corrales Garcia, Ligia ^a,b   Ortiz, Ernesto ^a   Castañeda Delgado, Julio ^c   Rivas Santiago, Bruno ^c   Corzo, Gerardo ^a  

^a INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Antimicrobial peptides; Human defensins; Mycobacterium tuberculosis; Peptide yields; Protein expression

Indexed keywords

BETA DEFENSIN; PEPTIDE; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; DRUG EFFECT; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MYCOBACTERIUM TUBERCULOSIS; PATHOGENICITY; STAPHYLOCOCCUS AUREUS;

AMINO ACID SEQUENCE; BETA-DEFENSINS; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PEPTIDES; RECOMBINANT PROTEINS; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MYCOBACTERIUM TUBERCULOSIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 84875451768     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2013.02.007     Document Type: Article

References (56)

1. S. Jovetic, Y. Zhu, G.L. Marcone, F. Marinelli, and J. Tramper β-lactam and glycopeptide antibiotics: first and last line of defense? Trends Biotechnol. 28 2010 596 604
2. L. Pallecchi, A. Bartoloni, F. Paradisi, and G.M. Rossolini Antibiotic resistance in the absence of antimicrobial use: mechanisms and implications Expert Rev. Anti-Infec. Ther. 6 2008 725 732
3. J. Lehmann, M. Retz, J. Harder, M. Krams, U. Kellner, J. Hartmann, K. Hohgräwe, U. Raffenberg, M. Gerber, T. Loch, K. Weichert-Jacobsen, and M. Stöckle Expression of human β-defensins 1 and 2 in kidneys with chronic bacterial infection BMC Infect. Dis. 20 2002 1 10
4. R.I. Lehrer, and T. Ganz Defensins of vertebrate animals Curr. Opin. Immunol. 14 2002 96 102
5. M. Zasloff Antimicrobial peptides of multicellular organisms Nature 415 2002 389 395
6. B.C. Schutte, J.P. Mitros, J.A. Bartlett, J.D. Walters, H.P. Jia, M.J. Welsh, T.L. Casavant, J. Paul, and B. McCray Discovery of five conserved β-defensin gene clusters using a computational search strategy PNAS 99 2002 2129 2133
7. W. Song, Y. Shi, M. Xiao, H. Lu, T. Qu, P. Li, Gang Wu, and Y. Tian In vitro bactericidal activity of recombinant human β-defensin-3 against pathogenic bacterial strains in human tooth root canal Int. J. Antimicrob. Agent 33 2009 237 243
8. T. Ganz Versatile defensins. Science 298 2002 977 978
9. T. Ganz The role of antimicrobial peptides in innate immunity Integr. Comp. Biol. 43 2003 300 304
10. E. Klüver, S. Schulz-Maronde, S. Scheid, B. Meyer, W.-G. Forssmann, and K. Adermann Structure-activity relation of human β-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity Biochemistry 44 2005 9804 9816
11. J.J. Schneider, A. Unholzer, M. Schaller, M. Schäfer-Korting, and H.C. Korting Human defensins J. Mol. Med. 83 2005 587 595
12. D.M. Hoover, Z. Wu, K. Tucker, W. Lu, and J. Lubkowski Antimicrobial characterization of human β-defensin 3 derivatives Antimicrob. Agent Chemother. 47 2003 2804 2809
13. J. Harder, J. Bartels, E. Christophers, and J.-M. Schröder Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic J. Biol. Chem. 276 2001 5707 5713
14. J.-M. Schröder, and J. Harder Human β-defensins-2 Int. J. Biochem. Cell Biol. 31 1999 645 651
15. M. Schwaab, S. Hansen, M.D. Pearson, S. Shagdarsuren, and S. Dazert Human β-defensins - at the front line of the peritonsillar abscess Eur. J. Clin. Microbiol. Infect. Dis. 2009 122
16. M. Mathews, H.P. Jia, J.M. Guthmiller, G. Losh, S. Graham, G.K. Johnson, B.F. Tack, and P.B. McCray Production of β-defensin antimicrobial peptides by the oral mucosa and salivary glands Infect. Immun. 67 1999 2740 2745
17. E.V. Valore, and T. Ganz Antibacterial Peptide Protocols 1997 Humana Press Inc. Tokowa NJ, USA
18. R.I. Lehrer, M. Rosenman, S.S.S.L. Harwig, R. Jackson, and P. Eisenhauer Ultrasensitive assay for endogenous antimicrobial polypeptides J. Immunol. Meth. 137 1991 167 173
19. J.C. Palomino, A. Martin, M. Camacho, H. Guerra, J. Swings, and F. Portaels Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis Antimicrob. Agent Chemother. 46 2002 2720 2722
20. A. Rodríguez, E. Villegas, H. Satake, L.D. Possani, and G. Corzo Amino acid substitutions in an alpha-helical antimicrobial arachnid peptide affect its chemical properties and biological activity towards pathogenic bacteria but improves its therapeutic index Amino Acids 40 2011 61 68
21. M. Zorko, B. Japel, I. Hafner-Bratkovič, and R. Jerala Expression, purification and structural studies of a short antimicrobial peptide Biochem. Biophys. Acta 1788 2009 314 323
22. Y. Li Recombinant production of antimicrobial peptides in Escherichia coli: a review Protein Expr. Purif. 80 2011 260 267
23. J.F. Kane Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli Curr. Opin. Biotechnol. 6 1995 494 500
24. N.A. Burgess-Brown, S. Sharma, F. Sobott, C. Loenarz, U. Oppermann, and O. Gileadi Codon optimization can improve expression of human genes in Escherichia coli: a multi-gene study Protein Expr. Purif. 59 2008 94 102
25. B.R. Glick, and G.K. Whitney Factors affecting the expression of foreign proteins in Escherichia coli J. Ind. Microbiol. 1 1987 277 282
26. L. Peng, Z. Xu, X. Fang, F. Wang, S. Yang, and P. Cen Preferential codons enhancing the expression level of human β-defensin-2 in recombinant Escherichia coli Protein Pept. Lett. 11 2004 339 344
27. L. Peng, Z. Xu, X. Fang, F. Wang, and P. Cen High-level epression of soluble human β-defensin-2 in Escherichia coli Process Biochem. 39 2004 2199 2205
28. Z. Xu, L. Peng, Z. Zhong, X. Fang, and P. Cen High-level expression of a soluble functional antimicrobial peptide, human β-defensin 2, in Escherichia coli Biotechnol. Prog. 22 2006 382 386
29. D. Esposito, and D.K. Chatterjee Enhancement of soluble protein expression through the use of fusion tags Curr. Opin. Biotechnol. 17 2006 353 358
30. I. Cipáková, E. Hostinová, J. Gasperík, and V. Velebny High-level expression and purification of a recombinant hBD-1fused to LMM protein in Escherichia coli Protein Expr. Purif. 37 2004 207 212
31. Z. Xu, Z. Zhong, L. Huang, L. Peng, F. Wang, and P. Cen High-level production of bioactive human β-defensin-4 in Escherichia coli by soluble fusion expression Appl. Microbiol. Biotechnol. 72 2006 471 479
32. T. Vargues, G.J. Morrison, E.S. Seo, D.J.C.L. Fielder, J. Bennani, U. Pathania, F. Kilanowski, J.R. Dorin, J.R.W. Govan, C.L. Mackay, D. Uhrín, and D.J. Campopiano Efficient production of human β-defensin 2 (hBD2) in Escherichia coli Protein Pept. Lett. 16 2009 668 676
33. F. Wang, X. Fang, Z. Xu, L. Peng, and P. Cen Fusion expression of human β-defensin-2 from multiple joined genes in Escherichia coli Prep. Biochem. Biotechnol. 34 2004 215 225
34. L.G. Si, X.C. Liu, Y.Y. Lu, G.Y. Wang, and W.M. Li Soluble expression of active human β-defensin-3 in Escherichia coli and its effects on the growth of host cells Chin. Med. J. 120 2007 708 713
35. M. Pazgier, and J. Lubkowski Expression and purifcation of recombinant human alpha-defensins in Escherichia coli Protein Expr. Purif. 49 2006 1 8
36. K.L. Piers, M.H. Brown, and R.E.W. Hancock Recombinant dna procedures for producing small antimicrobial cationic peptides in bacteria Gene 134 1993 7 13
37. B. Bommarius, H. Jenssen, M. Elliott, J. Kindrachuk, M. Pasupuleti, H. Gieren, K.-E. Jaeger, R.E.W. Hancock, and D. Kalman Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli Peptides 31 2010 1957 1965
38. L. Zhang, T. Falla, M. Wu, S. Fidai, J. Burian, W. Kay, and R.E.W. Hancock Determinants of recombinant production of antimicrobial cationic peptides and creation of peptide variants in bacteria Biochem. Biophys. Res. Commun. 247 1998 674 680
39. S.A. Jang, B.H. Sung, J.H. Cho, and S.C. Kim1 Direct expression of antimicrobial peptides in an intact form by a translationally coupled two-cistron expression system Appl. Environ. Microbiol. 75 2009 3980 3986
40. L.L. Corrales-Garcia, L.D. Possani, and G. Corzo Expression systems of human β-defensins: vectors, purification and biological activities Amino Acids 40 2011 5 13
41. Y.S. Kim, and H.J. Cha Disperse distribution of cationic amino acids on hydrophilic surface of helical wheel enhances antimicrobial peptide activity Biotechnol. Bioeng. 107 2010 216 223
42. O.L. Franco Peptide promiscuity: an evolutionary concept for plant defense Fed. Eur. Biochem. Soc. 585 2011 995 1000
43. R.E.W. Hancock, and D.S. Chapple Peptide antibiotics Antimicrob. Agent Chemother. 43 1999 1317 1323
44. R.E.W. Hancock, and G. Diamond The role of cationic antimicrobial peptides in innate host defences Trends Microbiol. 8 2000 402 410
45. P.K. Singh, H.P. Jia, K. Wiles, J. Hesselberth, L. Liu, B.-A.D. Conway, E.P. Greenberg, E.V. Valore, M.J. Welsh, T. Ganz, B.F. Tack, J. Paul, and B. Mccray Production of β-defensins by human airway epithelia PNAS 95 1998 14961 14966
46. L. Huang, J. Wang, Z. Zhong, L. Peng, H. Chen, Z. Xu, and P. Cen Production of bioactive human β-defensin-3 in Escherichia coli by soluble fusion expression Biotechnol. Lett. 28 2006 627 632
47. J. Harder, J. Bartels, E. Christophers, and J.-M. Schröder A peptide antibiotic from human skin Nature 387 1997 861
48. H.T. Chou, H.W. Wen, T.Y. Kuo, C.C. Lin, and W.J. Chen Interaction of cationic antimicrobial peptides with phospholipid vesicles and their antibacterial activity Peptides 31 2010 1811 1820
49. Z. Wu, D.M. Hoover, D. Yang, C. Boulègue, F. Santamaria, J.J. Oppenheim, J. Lubkowski, and W. Lu Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human β-defensin 3 PNAS 100 2003 8880 8885
50. D.J. Campopiano, D.J. Clarke, N.C. Polfer, P.E. Barran, R.J. Langley, J.R.W. Govan, A. Maxwell, and J.R. Dorin Structure-activity relationships in defensin dimers: a novel link between β-defensin tertiary structure and antimicrobial activity J. Biol. Chem. 279 2004 48671 48679
51. Z. Zhong, Z. Xu, L. Peng, L. Huang, X. Fang, and P. Cen Tandem repeat mhbd2 gene enhance the soluble fusion expression of hBD2 in Escherichia coli Appl. Microbiol. Biotechnol. 71 2006 661 667
52. R. Kapoor, P.R. Eimerman, J.W. Hardy, J.D. Cirillo, C.H. Contag, and A.E. Barron Efficacy of antimicrobial peptoids against Mycobacterium tuberculosis Antimicrob. Agent Chemother. 55 2011 3058 3062
53. B. Rivas-Santiago, S.K. Schwander, C. Sarabia, G. Diamond, M.E. Klein-Patel, R. Hernandez-Pando, J.J. Ellner, and E. Sada Human β-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells Infect. Immun. 73 2005 4505 4511
54. D. Lemus, E. Montoro, M. Echemendía, S.L. Yzquierdo, A. Martin, F. Portaels, and J.C. Palomino Nuevos métodos para la detección rápida de la resistencia de Micobacterium tuberculosis Biotechnol. Appl. 22 2005 306 308
55. N. Rastogi, V. Labrousse, and K.S. Goh In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages Curr. Microbiol. 33 1996 167 175
56. C.D. Fjell, J.A. Hiss, R.E.W. Hancock, and G. Schneider Designing antimicrobial peptides: form follows function Nat. Rev. Drug Discov. 11 2012 37 51